BRIGHT MINDS BIOSCIENCES INC. (DRUG) Stock buybacks
BRIGHT MINDS BIOSCIENCES INC. (DRUG) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DRUGSource: SEC XBRL filings · For reference only · Not investment advice
More DRUG financial trends
DRUG RevenueDRUG Net incomeDRUG Net marginDRUG Gross profitDRUG Gross marginDRUG Operating incomeDRUG Operating marginDRUG Operating cash flowDRUG Free cash flowDRUG Capital expendituresDRUG Return on equityDRUG Dividends paidDRUG Total assetsDRUG Total liabilitiesDRUG Shareholders’ equityDRUG overview →